No Data
MannKind (MNKD) Gets a Buy From Cantor Fitzgerald
Institutional Investors Have a Lot Riding on MannKind Corporation (NASDAQ:MNKD) With 55% Ownership
MannKind To Present At Leerink Partners Global Healthcare Conference; Webcast At 8:40 AM ET
MannKind to Present New Inhaled Insulin Data at Global Diabetes Conference in Amsterdam
MannKind Showcases Efficacy, Safety, and Mealtime Control Data From Recent Pediatric and Adult Studies of Afrezza at the ATTD Conference, March 19-22
MannKind Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
